To: Dan Packer who wrote (1471 ) 3/18/1998 9:58:00 PM From: David S. Read Replies (2) | Respond to
do not underestimate the potential market of these devices. For example, (the truth finally comes out), I am conducting clinical studies with CCSI. Darby will verify this. It is for the additional indication of determining the variety of virus that is causing the particular cold that people have. As you know, Agouron is working on a cure for colds, but viruses come in varieties, mutate, etc. This project, in collaboration with Agouron, uses CCSI technology to determine the subtle differences in boogers that people have. Traffic -light green boogers, for example denote one variety of cold virus. Brown ones are tricky, since they may just be old green ones, or be legitimate brown ones, which would require a different medication. Here again, the ability of the colormate to measure the color yellow comes into play. We have already determined that the degree of yellowness in boogers is an indication of how the subject has been infected, thereby we can infer how effective an antiviral would be if administered. So far, we are pleased with the results, with the only complicating factor being that the really good boogers are lodged quite far into the nasal cavity, making analysis somewhat difficult. Undeterred by this seemingly impossible, if not, unsightly hurdle, Chromatic Color Science is in the process of furthur miniturization of the colormate, with the stated goal of producing a prototype that can achieve full insertion up into either nostril within 18 months. Although our studies await the delivery of the device, we are taking this time to painstakingly analyze the samples already collected. Trial results will be presented at the Annual Convention of Nostril Handlers, sponsored by Kimberly-Clark.
